Dr Reddys Laboratories Ltd 6-K, filed Sep 12, 2024
Dr Reddys Laboratories Ltd (RDY)
About this 6-K
Dr Reddys Laboratories Ltd filed this 6-K on September 12, 2024.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
September, 2024
Commission File Number 1-15182
DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
+91-40-49002900
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.
EXHIBITS
|
Exhibit |
Description of Exhibits | |
| 99.1 | Intimation dated September 12, 2024 |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
DR. REDDY’S LABORATORIES LIMITED (Registrant) | |||
| Date: September 12, 2024 | By: | /s/ K Randhir Singh | |
| Name: | K Randhir Singh | ||
| Title: | Company Secretary | ||
| 3 |
Exhibit 99.1
 |
Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507
Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.com |
September 12, 2024
National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE Limited (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Dear Sir/Madam,
| Sub: | Results of voting through Postal Ballot (remote e-voting) pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
This is in furtherance to our letter dated August 13, 2024 enclosing therein Notice of Postal Ballot seeking approval of Members of the Company for sub-division/ split of each equity share of the Company having face value of Rs. 5/- (Rupees five only) each, fully paid-up, into 5 (Five) equity shares having face value of Re. 1/- (Rupee one only) each, fully paid up, and consequent alteration of the Capital Clause of the Memorandum of Association of the Company, by way of ordinary resolution through remote e-voting.
We would like to inform that the ordinary resolution as set out in the said Postal Ballot Notice has been approved by the Members of the Company with requisite majority.
In accordance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the summarized voting result of the remote e-voting , in the prescribed format, along with a copy of the Scrutinizer’s Report are enclosed herewith, for your information and records. The same is also being made available on the Company’s website, www.drreddys.com.
This is for your information and records.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer & Head-CSR
Encl: as above
CC: National Securities Depositary Limited (NSDL)
| General information about company | |
| Scrip code | 500124 |
| NSE Symbol | DRREDDY |
| MSEI Symbol | NOTLISTED |
| ISIN | INE089A01023 |
| Name of the company | Dr. Reddy's Laboratories Limited |
| Type of meeting | Postal Ballot |
| Date of the meeting / last day of receipt of postal ballot forms (in case of Postal Ballot) | 12-09-2024 |
| Start time of the meeting | |
| End time of the meeting | |
| Scrutinizer Details | |
| Name of the Scrutinizer | Alifya Sapatwala |
| Firms Name | Mehta & Mehta |
| Qualification | CS |
| Membership Number | 24091 |
| Date of Board Meeting in which appointed | 27-07-2024 |
| Date of Issuance of Report to the company | 12-09-2024 |
| Voting results | |
| Record date | 09-08-2024 |
| Total number of shareholders on record date | 284425 |
| No. of shareholders present in the meeting either in person or through proxy | |
| a) Promoters and Promoter group | |
| b) Public | |
| No. of shareholders attended the meeting through video conferencing | |
| a) Promoters and Promoter group | |
| b) Public | |
| No. of resolution passed in the meeting | 1 |
| Resolution (1) | |
| Resolution required: (Ordinary / Special) | Ordinary |
| Whether promoter/promoter group are interested in the agenda/resolution? | No |
| Description of resolution considered | Approval of sub-division/split of each equity share of Rs. 5/- (Rupees five only) each into 5 (five) equity shares of Re. 1/- (Rupee one only) each and consequent alteration to the Memorandum of Association of the Company |
| Category | Mode of voting | No. of shares held | No. of votes polled | % of Votes polled on outstanding shares | No. of votes – in favour | No. of votes – against | % of votes in favour on votes polled | % of Votes against on votes polled | ||||||||||||||||||||||
| (1) | (2) | (3)=[(2)/(1)]*100 | (4) | (5) | (6)=[(4)/(2)]*100 | (7)=[(5)/(2)]*100 | ||||||||||||||||||||||||
| Promoter and Promoter Group | E-Voting | 44461128 | 100.0000 | 44461128 | 0 | 100.0000 | 0.0000 | |||||||||||||||||||||||
| Poll | 44461128 | 0 | 0.0000 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
| Postal Ballot (if applicable) | 0 | 0.0000 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Total | 44461128 | 44461128 | 100.0000 | 44461128 | 0 | 100.0000 | 0.0000 | |||||||||||||||||||||||
| Public- Institutions | E-Voting | 90885450 | 84.7784 | 90726574 | 158876 | 99.8252 | 0.1748 | |||||||||||||||||||||||
| Poll | 107203568 | 0 | 0.0000 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
| Postal Ballot (if applicable) | 0 | 0.0000 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Total | 107203568 | 90885450 | 84.7784 | 90726574 | 158876 | 99.8252 | 0.1748 | |||||||||||||||||||||||
| Public- Non Institutions | E-Voting | 245993 | 1.6221 | 243963 | 2030 | 99.1748 | 0.8252 | |||||||||||||||||||||||
| Poll | 15165005 | 0 | 0.0000 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
| Postal Ballot (if applicable) | 0 | 0.0000 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Total | 15165005 | 245993 | 1.6221 | 243963 | 2030 | 99.1748 | 0.8252 | |||||||||||||||||||||||
| Total | 166829701 | 135592571 | 81.2760 | 135431665 | 160906 | 99.8813 | 0.1187 | |||||||||||||||||||||||
| Whether resolution is Pass or Not. | Yes | |||||||||||||||||||||||||||||
| Details of Invalid Votes | ||||
| Category | No. of Votes | |||
| Promoter and Promoter Group | 0 | |||
| Public Institutions | 0 | |||
| Public - Non Institutions | 0 | |||
